Reshape Biotech
Private Company
Total funding raised: $1.8M
Overview
Reshape Biotech, founded in 2019 and based in Copenhagen, is a technology company focused on automating and digitizing laboratory workflows. Its core offering is an integrated ecosystem of robotic hardware (smart incubators, high-throughput imagers) and a cloud software platform that uses AI to automatically image and analyze plate-based microbiological assays. The platform targets R&D and quality control labs, aiming to reduce manual work, minimize errors, and generate standardized, searchable data to accelerate research. Customer testimonials highlight significant reductions in false negatives and massive increases in screening throughput.
Technology Platform
Integrated ecosystem of robotic lab hardware (smart incubators, high-throughput imagers) and a cloud-based AI software platform (Discovery Platform) that automates imaging and analysis of plate-based microbiological assays.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Reshape operates in the competitive lab automation and AI-for-science space. It competes with large instrument manufacturers (e.g., Thermo Fisher, Agilent, PerkinElmer) offering robotic systems, and with software-focused startups providing AI image analysis for life sciences. Its differentiated integrated hardware-software platform and focus on microbiological assays provide a niche, but it must continually innovate against both broad and specialized competitors.